Chinh V. Tran - San Diego CA, US Frank Ruebsam - San Diego CA, US Yuefen Zhou - San Diego CA, US Peter Dragovich - San Diego CA, US Alan X. Xiang - San Diego CA, US
Assignee:
Anadys Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 417/04 A61K 31/549
US Classification:
5142232, 544 12, 544 13
Abstract:
The invention is directed to 5,6-dihydro-1H-pyridin-2-one compounds of Formula I and pharmaceutical compositions containing such compounds that are useful in treating hepatitis C virus infections:.
Stephen E. Webber - San Diego CA, US Frank Ruebsam - San Diego CA, US Martin Tran - San Diego CA, US Peter Dragovich - San Diego CA, US Liansheng Li - San Diego CA, US Douglas Eric Murphy - San Diego CA, US David Kucera - Del Mar CA, US Zhongxiang Sun - San Diego CA, US Chinh Viet Tran - San Diego CA, US
Assignee:
Anadys Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 513/04 A61K 31/542 A61K 31/5415
US Classification:
544 13, 5142233
Abstract:
The invention is directed to pyrro[1,2-b]pyridazinone compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.
David Ellis - San Diego CA, US Liansheng Li - San Diego CA, US Chinh V. Tran - San Diego CA, US Frank Ruebsam - San Diego CA, US Yuefen Zhou - San Diego CA, US
Assignee:
Anadys Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 417/04 A61K 31/549
US Classification:
5142232, 544 12, 544 13
Abstract:
The invention is directed to 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds of Formula I and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus:.
Stephen E. Webber - San Diego CA, US Frank Ruebsam - San Diego CA, US Martin Tran - San Diego CA, US Peter Dragovich - San Diego CA, US Liansheng Li - San Diego CA, US Douglas Eric Murphy - San Diego CA, US David Kucera - Del Mar CA, US Zhongxiang Sun - San Diego CA, US Chinh Viet Tran - San Diego CA, US
Assignee:
Anadys Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07C 303/00
US Classification:
564 86, 564 81
Abstract:
The invention is directed to pyrro[1,2-b]pyridazinone compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.
Steven Joseph Berthel - Mendham Township NJ, US Robert Francis Kester - West Orange NJ, US Douglas Eric Murphy - San Diego NJ, US Thomas Jay Prins - San Diego CA, US Frank Ruebsam - San Diego CA, US Chinh Viet Tran - San Diego CA, US Dionisios Vourloumis - Athens, GR
Steven Joseph Berthel - Mendham Township, Morris County NJ, US Robert Francis Kester - West Orange NJ, US Douglas Eric Murphy - San Diego CA, US Thomas Jay Prins - San Diego CA, US Frank Ruebsam - San Diego CA, US Ramakanth Sarabu - Towaco NJ, US Chinh Viet Tran - San Diego CA, US Dionisios Vourloumis - Athens, GR
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 31/5377 A61K 31/415 A61P 3/00 C07D 231/00
US Classification:
5142365, 514407, 544140, 5483725
Abstract:
Disclosed herein are pyrazole glucokinase activators of the formula (I).
Chinh V. Tran - San Diego CA, US Frank Ruebsam - San Diego CA, US Douglas E. Murphy - San Diego CA, US Peter Dragovich - San Diego CA, US Yuefen Zhou - San Diego CA, US Lijian Chen - Encinitas CA, US David Kucera - Del Mar CA, US
Assignee:
Anadys Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 413/04 C07D 491/04 A61K 31/549
US Classification:
5142232, 544 12, 544 13
Abstract:
The invention is directed to 5,6-dihydro-1H-pyridin-2-one compounds of Formula I.
Frank Ruebsam - San Diego CA, US Peter Dragovich - San Diego CA, US Stephen E. Webber - San Diego CA, US Douglas Eric Murphy - San Diego CA, US Chinh Viet Tran - San Diego CA, US
Assignee:
Anadys Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 513/04 A61K 31/542
US Classification:
5142228, 544 10, 544 12, 5142232
Abstract:
The invention is directed to [1,2,4]thiadiazine 1,1-dioxide compounds of formula I.